Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
3.910
+0.160 (4.27%)
At close: Sep 26, 2025, 4:00 PM EDT
4.000
+0.090 (2.30%)
After-hours: Sep 26, 2025, 7:49 PM EDT
Fortress Biotech Revenue
Fortress Biotech had revenue of $16.41M in the quarter ending June 30, 2025, with 10.18% growth. This brings the company's revenue in the last twelve months to $59.30M, down -28.23% year-over-year. In the year 2024, Fortress Biotech had annual revenue of $57.68M, down -31.76%.
Revenue (ttm)
$59.30M
Revenue Growth
-28.23%
P/S Ratio
1.67
Revenue / Employee
$587,139
Employees
101
Market Cap
116.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57.68M | -26.84M | -31.76% |
Dec 31, 2023 | 84.51M | 8.77M | 11.58% |
Dec 31, 2022 | 75.74M | 6.95M | 10.11% |
Dec 31, 2021 | 68.79M | 23.19M | 50.86% |
Dec 31, 2020 | 45.60M | 8.97M | 24.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
FBIO News
- 24 days ago - Journey Medical Corporation to Participate in September 2025 Investor Conferences - GlobeNewsWire
- 25 days ago - Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation to Present at the Emerging Growth Conference - GlobeNewsWire
- 6 weeks ago - Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - GlobeNewsWire